tiprankstipranks
Trending News
More News >

MaxCyte Announces Change in Major Shareholder Voting Rights

Story Highlights
MaxCyte Announces Change in Major Shareholder Voting Rights

Confident Investing Starts Here:

MaxCyte ( (MXCT) ) has provided an update.

MaxCyte, Inc. has announced a change in the voting rights held by BlackRock, Inc., a major shareholder. BlackRock’s voting rights in MaxCyte have increased to 8.24% from a previous 7.90%, indicating a significant acquisition of shares and financial instruments. This adjustment in holdings may influence MaxCyte’s strategic decisions and reflects BlackRock’s growing interest in the company’s potential within the biotechnology sector.

More about MaxCyte

MaxCyte, Inc. operates in the biotechnology industry, providing cell-engineering platform technologies that enable the development and commercialization of next-generation cell-based therapies. The company focuses on enhancing the capabilities of its partners in the development of innovative medical treatments.

For detailed information about MXCT stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App